17 completed, 5 recruiting, 1 active not recruiting, 1 terminated. 5 Phase 2, 3 Phase 4, 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Active not recruiting 1 |
| Phase 4 | 3 | Recruiting 2, Completed 1 |
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow Janssen Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) Guselkumab (Tremfya) - Inflammatory Bowel Disease (IBD), Crohn Disease (CD) | Recruiting | TIDHI Innovation Inc. | 200 | 2026-01-29 | 2026-08-31 | |
| De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis Ustekinumab 90 mg SC q8w, Ustekinumab 90 mg SC q12w - Crohn Disease (CD), Ulcerative Colitis (UC) | Phase 4 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 115 | 2025-10-08 | 2025-12-26 |
| Plan Development for Giving Teclistamab in the Outpatient Setting Teclistamab, Tocilizumab - Multiple Myeloma, Relapsed Cancer | Phase 4 | Recruiting | University Health Network, Toronto | 15 | 2024-11-19 | 2025-12-10 |
| Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma Methotrexate, Rituximab (where available), Ibrutinib - Non-hodgkin Lymphoma | Phase 2 | Recruiting | Canadian Cancer Trials Group | 30 | 2024-02-13 | 2026-09-15 |
| Risk of Breakthrough Symptoms With Long-Acting Injectable Medications Second Generation Long-Acting Injectable Antipsychotic Medications - Schizophrenia, Schizophrenia Relapse | Completed | Centre for Addiction and Mental Health | 51 | 2023-01-11 | 2026-04-14 | |
| Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab - Prostate Cancer | Phase 2 | Recruiting | University of British Columbia | 315 | 2021-09-21 | 2026-08-14 |
| Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Abiraterone Acetate, Apalutamide, Leuprolide Acetate - Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation | Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 28 | 2021-03-17 | 2026-02-05 |
| Golimumab for Adherence in Rheumatoid Arthritis Golimumab - Arthritis, Rheumatoid | Completed | Janssen Inc. | 222 | 2019-01-15 | 2024-07-18 | |
| Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF) Canagliflozin 100mg, Placebo oral capsule, PET imaging - Type2 Diabetes, Heart Failure | Not applicable | Withdrawn | Université de Sherbrooke | 2018-05-01 | 2024-12-13 | |
| A Study of Participants With Advanced Prostate Cancer in Canada Standard of Care - Prostatic Neoplasms | Completed | Janssen Inc. | 374 | 2018-04-12 | 2023-07-25 | |
| Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection Paliperidone Palmitate, Risperidal Consta, Antipsychotic - Schizophrenia Spectrum and Other Psychotic Disorders | Unknown | Réseau de Santé Vitalité Health Network | 328 | 2018-01-02 | 2018-01-04 | |
| Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting Type 2 Diabetes Mellitus | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 269 | 2016-03-01 | 2016-09-13 | |
| An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada No Intervention - Diabetes Mellitus, Type 2 | Completed | Janssen Inc. | 538 | 2015-11-13 | 2017-10-30 | |
| Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. Disease evaluation. - Rheumatoid Arthritis, Psoriatic Arthritis | Completed | Isabelle Fortin | 80 | 2015-09-01 | 2019-02-01 | |
| Observational Study of Golimumab Intravenous Infusion Golimumab Intravenous - Rheumatoid Arthritis | Terminated | Janssen Inc. | 78 | 2015-02-01 | 2016-11-17 | |
| A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry - Prostatic Neoplasms | Completed | Janssen Inc. | 194 | 2014-09-30 | 2019-12-06 | |
| Prucalopride Versus Placebo in Gastroparesis Prucalopride, Placebo - Gastroparesis, Diabetes Mellitus | Phase 2 / Phase 3 | Completed | University of Calgary | 15 | 2014-03-01 | 2020-10-08 |
| Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule Prucalopride, Colon Capsule - Bowel Cleansing, Colon Capsule Completion Times | Phase 3 | Completed | Queen's University | 60 | 2013-06-01 | 2017-02-16 |
| Infliximab IBD Influenza Vaccine Study Influenza vaccination - Inflammatory Bowel Disease | Not applicable | Completed | University of Calgary | 137 | 2012-09-01 | 2016-05-09 |
| The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy Infliximab 5 mg/kg body weight infused over 2 hours - Crohn's Disease | Phase 4 | Completed | Janssen Inc. | 1 | 2012-06-01 | 2013-12-16 |
Showing 20 of 26. Sign in to see all of them.
Arthritis, Rheumatoid (5) · Crohn Disease (4) · Prostatic Neoplasms (4) · Inflammatory Bowel Diseases (3) · Arthritis, Psoriatic (2) · Colitis, Ulcerative (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Recurrence (2) · Acquired Immunodeficiency Syndrome (1) · Anemia (1) · Axial Spondyloarthritis (1) · Gastroparesis (1) · Heart Failure (1) · Influenza, Human (1)
Abiraterone Acetate (3) · Paliperidone Palmitate (2) · Risperidone (2) · apalutamide (2) · golimumab (2) · guselkumab (2) · prucalopride (2) · Adalimumab (1) · Antipsychotic Agents (1) · Aripiprazole (1) · Canagliflozin (1) · Darunavir (1) · Docetaxel (1) · Infliximab (1) · Influenza Vaccines (1)
Canada (24) · United States (3) · Belgium (1) · Germany (1) · Poland (1)
Amar Kishan (1) · Anca Prica (1) · Christine Chen, Dr. (1) · Christopher N Andrews, MD, MSc (1) · Janice S Cohen, Ph.D. (1) · Jean-Francois Larouche (1) · Laura E. Targownik, MD, MSHS, FRCPC (1) · Lawrence Hookey (1) · Mark Silverberg, MD, PhD, FRCPC (1) · Martin E Gleave, MD (1)
PMID 16291813, PMID 17444590, PMID 19918045, PMID 20215140, PMID 20235213, PMID 20237122, PMID 20461787, PMID 22417647, PMID 22473918, PMID 22562935, PMID 23928236, PMID 24046468, PMID 24332117, PMID 25365082, PMID 26077415, PMID 26154787, PMID 26509071, PMID 27048632, PMID 28855200, PMID 32792436, PMID 32968710, PMID 33292797, PMID 37263649, PMID 37906417, PMID 38494380, PMID 40585577, PMID 40971024